N = 113 | |
---|---|
Characteristic | |
Age, years | 66.5 ± 7.6 |
Male gender | 101 (89.4%) |
Body-mass index, kg/m2 | 28.4 ± 3.9 |
Diabetes mellitus | 33 (29.2%) |
Current smoker | 15 (13.3%) |
Hypertension | 88 (77.9%) |
Hyperlipidemia | 99 (87.6%) |
Acute coronary syndrome* | 21 (18.6%) |
Heart failure NYHA class 3-4 | 23 (20.4%) |
Preoperative laboratory values | |
Baseline high-density lipoprotein, mg/dL | 38.4 ± 11.2 |
Baseline low-density lipoprotein, mg/dL | 72.8 ± 30.0 |
Baseline creatinine, μmol/L | 89.0 ± 17.5 |
Preoperative medication use | |
Aspirin | 104 (92.0%) |
Clopidogrel | 12 (10.6%) |
Statin | 101 (89.4%) |
Beta-blocker | 87 (77.0%) |
Angiotensin converting enzyme | |
Inhibitor | 57 (50.4%) |
Postoperative medication use (at discharge) | |
Aspirin | 113 (100%) |
Clopidogrel | 56 (49.6%) |
Statin | 103 (91.2%) |
Beta-blocker | 105 (92.9%) |
Angiotensin converting enzyme | |
Inhibitor | 40 (35.4%) |
Operative details | |
Number of distal anastomoses | 3.5 ± 0.7 |
Left internal thoracic graft | 112 (99.1%) |
Right internal thoracic graft | 22 (19.5%) |
Cross-clamp time, min | 64.5 ± 20.1 |
Cardiopulmonary bypass time, min | 90.1 ± 24.6 |
Off-pump surgery | 4 (3.5%) |
Length of stay | |
Duration in intensive care, days | 1.4 ± 1.0 |
Duration in hospital, days | 8.7 ± 5.8 |